Acute Urticaria
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers
Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria
Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria